MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from
at-the-market offerings, net...
$62,778K
Proceeds from issuance of
common stock under...
$17,605K
Sales and maturities
of marketable...
$64,045K
(-17.69%↓ Y/Y)
Purchase of property and
equipment
-$2K
(-103.92%↓ Y/Y)
Net cash provided by
financing activities
$79,846K
(3992200.00%↑ Y/Y)
Net cash provided by
investing activities
$9,635K
(-68.51%↓ Y/Y)
Canceled cashflow
$537K
Canceled cashflow
$54,412K
Net change in cash,
cash equivalents and...
$45,121K
(506.57%↑ Y/Y)
Canceled cashflow
$44,360K
Payment of transaction
costs
$537K
Stock-based compensation
$10,797K
(48.82%↑ Y/Y)
Accounts payable
$1,785K
(9.51%↑ Y/Y)
Noncash operating lease
expense
$972K
(-3.95%↓ Y/Y)
Depreciation
$463K
(-25.56%↓ Y/Y)
Other, net
-$21K
(-137.50%↓ Y/Y)
Other long-term
assets
-$10K
(-900.00%↓ Y/Y)
Purchases of marketable
securities
$54,412K
(15.37%↑ Y/Y)
Net cash used in
operating activities
-$44,360K
(-6.39%↓ Y/Y)
Canceled cashflow
$14,048K
Net loss
-$45,514K
(-14.14%↓ Y/Y)
Accrued expenses and
other liabilities
-$8,690K
(-41.90%↓ Y/Y)
Prepaid expenses and
other current assets
$2,299K
(454.24%↑ Y/Y)
Accretion on marketable
securities
-$1,124K
(-76.18%↓ Y/Y)
Operating lease
liabilities
-$781K
(-0.13%↓ Y/Y)
Back
Back
Cash Flow
TNGX_BIG
Tango Therapeutics, Inc. (TNGX)
TNGX_BIG
source: myfinsight.com
Tango Therapeutics, Inc. (TNGX)